Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GOSS – Gossamer Bio Inc.

GOSS — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

19.66

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.08

EPS Last/This Y

0.26

EPS This/Next Y

0.3

Price

0.33

Target Price

3.69

Analyst Recom

2.56

Performance Q

-87.97

Upside

-8,054.5%

Beta

2.22

Ticker: GOSS




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09GOSS0.55540.520.54406060
2026-03-10GOSS0.51280.520.75405373
2026-03-11GOSS0.49010.520.27405169
2026-03-12GOSS0.46990.525.82405336
2026-03-13GOSS0.460.525.82405336
2026-03-17GOSS0.4720.510.38403963
2026-03-18GOSS0.43410.510.32404266
2026-03-19GOSS0.43770.5128.93403787
2026-03-20GOSS0.42240.342.85359144
2026-03-23GOSS0.37010.161.6478783
2026-03-24GOSS0.34490.160.3378876
2026-03-25GOSS0.38290.150.9979868
2026-03-26GOSS0.38280.150.9779799
2026-03-27GOSS0.34590.150.2280062
2026-03-30GOSS0.3240.150.1780004
2026-03-31GOSS0.33080.150.2880012
2026-04-01GOSS0.36340.150.2080275
2026-04-02GOSS0.36360.153.1780523
2026-04-06GOSS0.34350.150.8780580
2026-04-07GOSS0.32580.151.8681074
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09GOSS0.56-35.9141.5-0.72
2026-03-10GOSS0.51-35.9141.9-0.72
2026-03-11GOSS0.49-35.9142.1-0.72
2026-03-12GOSS0.47-35.9142.3-0.72
2026-03-13GOSS0.44-30.4142.6-0.72
2026-03-17GOSS0.47-30.4142.3-0.72
2026-03-18GOSS0.43-30.4142.6-0.72
2026-03-19GOSS0.44-30.4142.6-0.72
2026-03-20GOSS0.42-18.7142.8-0.58
2026-03-23GOSS0.37-18.7141.4-0.58
2026-03-24GOSS0.34-18.7154.8-0.58
2026-03-25GOSS0.38-18.7154.5-0.58
2026-03-26GOSS0.38-18.7154.5-0.58
2026-03-27GOSS0.35-18.7154.7-0.58
2026-03-30GOSS0.32-6.2154.9-0.49
2026-03-31GOSS0.33-6.2154.8-0.49
2026-04-01GOSS0.36-6.2154.6-0.49
2026-04-02GOSS0.37-6.2154.6-0.49
2026-04-06GOSS0.34-6.2154.8-0.49
2026-04-07GOSS0.33-6.2154.7-0.49
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09GOSS0.00-3.0516.93
2026-03-10GOSS0.00-3.0516.93
2026-03-11GOSS0.00-3.0518.90
2026-03-12GOSS0.00-3.0518.90
2026-03-13GOSS0.00-3.0518.90
2026-03-17GOSS0.00-1.4018.90
2026-03-18GOSS0.00-1.4018.90
2026-03-19GOSS0.00-1.4018.90
2026-03-20GOSS0.00-1.4018.64
2026-03-23GOSS0.00-1.3718.64
2026-03-24GOSS0.00-1.3718.64
2026-03-25GOSS0.00-1.3719.66
2026-03-26GOSS0.00-1.3719.66
2026-03-27GOSS0.00-1.3719.66
2026-03-30GOSS0.00-1.3719.66
2026-03-31GOSS0.00-1.3719.66
2026-04-01GOSS0.00-1.3719.66
2026-04-02GOSS0.00-1.3719.66
2026-04-06GOSS0.00-2.6819.66
2026-04-07GOSS0.00-2.6819.66
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

Institutional Transactions

-2.68

Beta

2.22

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

3

Fair Value

Quality Score

8

Growth Score

24

Sentiment Score

26

Actual DrawDown %

97.9

Max Drawdown 5-Year %

-97.8

Target Price

3.69

P/E

Forward P/E

PEG

P/S

1.6

P/B

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y​

-0.49

EPS Next Y. (Est.)

-0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-351.49

Relative Volume

0.51

Return on Equity vs Sector %

111.3

Return on Equity vs Industry %

127.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

154.7
GOSS Healthcare
$0.33
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
8/20
Pullback
13/25
Volume
11/15
Valuation
12/20
TP/AR
0/10
Options
6/10
RSI
26.9
Range 1M
0.8%
Sup Dist
1%
🚀
Momentum Growth
Ride accelerating trends
N/A
25 /100
WEAK
Momentum
3/25
Growth
15/30
Estimates
0/20
Inst/Vol
0/15
Options
7/10
EPS Yr
38.2%
EPS NY
68.6%
52W%
0.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +1018.2% upside
Quality
7/30
Valuation
16/30
Growth
14/25
Stability
7/10
LT Trend
4/5
Upside
+1018.2%
Quality
8
Gossamer Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 161
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
GOSS

Latest News

Caricamento notizie per GOSS
stock quote shares GOSS – Gossamer Bio Inc. Stock Price stock today
news today GOSS – Gossamer Bio Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GOSS – Gossamer Bio Inc. yahoo finance google finance
stock history GOSS – Gossamer Bio Inc. invest stock market
stock prices GOSS premarket after hours
ticker GOSS fair value insiders trading

GOSS – Gossamer Bio, Inc.

GOSS — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

19.66

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.08

EPS Last/This Y

0.26

EPS This/Next Y

0.3

Price

0.33

Target Price

3.69

Analyst Recom

2.56

Performance Q

-87.97

Upside

-8,054.5%

Beta

2.22

Ticker: GOSS




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09GOSS0.55540.520.54406060
2026-03-10GOSS0.51280.520.75405373
2026-03-11GOSS0.49010.520.27405169
2026-03-12GOSS0.46990.525.82405336
2026-03-13GOSS0.460.525.82405336
2026-03-17GOSS0.4720.510.38403963
2026-03-18GOSS0.43410.510.32404266
2026-03-19GOSS0.43770.5128.93403787
2026-03-20GOSS0.42240.342.85359144
2026-03-23GOSS0.37010.161.6478783
2026-03-24GOSS0.34490.160.3378876
2026-03-25GOSS0.38290.150.9979868
2026-03-26GOSS0.38280.150.9779799
2026-03-27GOSS0.34590.150.2280062
2026-03-30GOSS0.3240.150.1780004
2026-03-31GOSS0.33080.150.2880012
2026-04-01GOSS0.36340.150.2080275
2026-04-02GOSS0.36360.153.1780523
2026-04-06GOSS0.34350.150.8780580
2026-04-07GOSS0.32580.151.8681074
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09GOSS0.56-35.9141.5-0.72
2026-03-10GOSS0.51-35.9141.9-0.72
2026-03-11GOSS0.49-35.9142.1-0.72
2026-03-12GOSS0.47-35.9142.3-0.72
2026-03-13GOSS0.44-30.4142.6-0.72
2026-03-17GOSS0.47-30.4142.3-0.72
2026-03-18GOSS0.43-30.4142.6-0.72
2026-03-19GOSS0.44-30.4142.6-0.72
2026-03-20GOSS0.42-18.7142.8-0.58
2026-03-23GOSS0.37-18.7141.4-0.58
2026-03-24GOSS0.34-18.7154.8-0.58
2026-03-25GOSS0.38-18.7154.5-0.58
2026-03-26GOSS0.38-18.7154.5-0.58
2026-03-27GOSS0.35-18.7154.7-0.58
2026-03-30GOSS0.32-6.2154.9-0.49
2026-03-31GOSS0.33-6.2154.8-0.49
2026-04-01GOSS0.36-6.2154.6-0.49
2026-04-02GOSS0.37-6.2154.6-0.49
2026-04-06GOSS0.34-6.2154.8-0.49
2026-04-07GOSS0.33-6.2154.7-0.49
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09GOSS0.00-3.0516.93
2026-03-10GOSS0.00-3.0516.93
2026-03-11GOSS0.00-3.0518.90
2026-03-12GOSS0.00-3.0518.90
2026-03-13GOSS0.00-3.0518.90
2026-03-17GOSS0.00-1.4018.90
2026-03-18GOSS0.00-1.4018.90
2026-03-19GOSS0.00-1.4018.90
2026-03-20GOSS0.00-1.4018.64
2026-03-23GOSS0.00-1.3718.64
2026-03-24GOSS0.00-1.3718.64
2026-03-25GOSS0.00-1.3719.66
2026-03-26GOSS0.00-1.3719.66
2026-03-27GOSS0.00-1.3719.66
2026-03-30GOSS0.00-1.3719.66
2026-03-31GOSS0.00-1.3719.66
2026-04-01GOSS0.00-1.3719.66
2026-04-02GOSS0.00-1.3719.66
2026-04-06GOSS0.00-2.6819.66
2026-04-07GOSS0.00-2.6819.66
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

Institutional Transactions

-2.68

Beta

2.22

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

3

Fair Value

Quality Score

8

Growth Score

24

Sentiment Score

26

Actual DrawDown %

97.9

Max Drawdown 5-Year %

-97.8

Target Price

3.69

P/E

Forward P/E

PEG

P/S

1.6

P/B

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y​

-0.49

EPS Next Y. (Est.)

-0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-351.49

Relative Volume

0.51

Return on Equity vs Sector %

111.3

Return on Equity vs Industry %

127.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

154.7
GOSS Healthcare
$0.33
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
8/20
Pullback
13/25
Volume
11/15
Valuation
12/20
TP/AR
0/10
Options
6/10
RSI
26.9
Range 1M
0.8%
Sup Dist
1%
🚀
Momentum Growth
Ride accelerating trends
N/A
25 /100
WEAK
Momentum
3/25
Growth
15/30
Estimates
0/20
Inst/Vol
0/15
Options
7/10
EPS Yr
38.2%
EPS NY
68.6%
52W%
0.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +1018.2% upside
Quality
7/30
Valuation
16/30
Growth
14/25
Stability
7/10
LT Trend
4/5
Upside
+1018.2%
Quality
8
Gossamer Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 161
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
GOSS

Latest News

Caricamento notizie per GOSS
stock quote shares GOSS – Gossamer Bio, Inc. Stock Price stock today
news today GOSS – Gossamer Bio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GOSS – Gossamer Bio, Inc. yahoo finance google finance
stock history GOSS – Gossamer Bio, Inc. invest stock market
stock prices GOSS premarket after hours
ticker GOSS fair value insiders trading